Medication info
Rosugrine 10mg (Rosuvastatin Calcium)

Rosugrine 10mg (Rosuvastatin Calcium)

Prescription medicationTablet
Ingredient · strength
Rosuvastatin Calcium›10.4mg / 1 tablet
Manufacturer / importer
Sears Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
30 tablets (15 tablets/ blister x 2)
Approval status
Active

MFDS item code 201903080 · Approved 2019.05.13 · Insurance code 689000790

Summary

Main use
Improvement of dyslipidemia, inhibition of atherosclerosis progression, and reduction of cardiovascular disease risk
Who uses it
Adults · Children
Adult dosage
5 milligrams once daily; if greater LDL cholesterol reduction is required, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient to control most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient response, and may be increased up to a maximum of 20 milligrams daily. Elderly: No dose adjustment is necessary. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering this drug at 20 mg to patients with moderate renal impairment. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or lower, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this drug to patients with active liver disease. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this drug is contraindicated in some of these patients.
Children's dosage
Age 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on administration of doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years: Safety and efficacy have not been established.

Ingredients

Manufacturer
Sears Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of dyslipidemia, inhibition of atherosclerosis progression, and reduction of cardiovascular disease risk

  • Hypercholesterolemia
  • hyperlipidemia
  • atherosclerosis
  • dysbetalipoproteinemia
  • coronary heart disease
  • stroke
  • myocardial infarction
View approved original text

This medication is used in various conditions related to hypercholesterolemia. It is used as an adjunct when diet and exercise alone do not control common hypercholesterolemia and mixed hyperlipidemia. It is also effective as an adjunct to diet in patients with homozygous familial hypercholesterolemia or primary dysbetalipoproteinemia. It may help lower cholesterol levels in pediatric patients aged 10 to 17 years with heterozygous familial hypercholesterolemia. Additionally, it is used to reduce the risk of stroke, myocardial infarction, and revascularization in adult patients at high risk for cardiovascular disease. This medication effectively improves cholesterol and other lipid levels for these conditions, enhancing health.

Dosage and Administration

Adult dosage

5 milligrams once daily; if greater LDL cholesterol reduction is required, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient to control most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient response, and may be increased up to a maximum of 20 milligrams daily. Elderly: No dose adjustment is necessary. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering this drug at 20 mg to patients with moderate renal impairment. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or lower, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this drug to patients with active liver disease. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this drug is contraindicated in some of these patients.

Children's dosage

Age 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on administration of doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years: Safety and efficacy have not been established.

Precautions

This medication should not be used by individuals who are allergic to specific components. Patients with severe liver dysfunction or unexplained elevated liver enzyme levels should also not take this medication. Individuals with muscle disorders or a history of muscle problems should not use this medication. Particularly in patients taking a medication called cyclosporine, this medication should not be used. Patients with severely impaired kidney function should also avoid this medication. Women who are pregnant or breastfeeding, as well as those who could become pregnant, must consult a physician before using this medication and should use appropriate contraceptive methods. Patients at high risk for muscle-related side effects are prohibited from using high doses of this medication. This medication contains lactose, so individuals with genetic issues like lactose intolerance should not take it. Individuals who consume excessive alcohol or have a history of liver disease should use this medication cautiously and have regular liver function tests. If symptoms such as muscle pain or weakness arise, they should immediately inform their healthcare provider, and this medication may be discontinued if necessary. Caution is required when using this medication in combination with certain drugs, as this may increase blood concentration and the risk of muscle side effects. Since this medication can affect liver and kidney function, regular monitoring is necessary. This medication should not be used during pregnancy or breastfeeding, and women planning to become pregnant should consult their healthcare provider. In the case of overdose, there is no specific antidote, so treatment should be symptomatic while monitoring liver function and muscle enzyme levels. Dizziness may occur when taking this medication, so caution should be exercised while driving or operating machinery. If a rash or severe allergic reaction occurs while taking this medication, it should be stopped immediately and medical assistance sought.

Side effects

Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular muscle weakness, thrombocytopenia, jaundice, hepatitis, increase in transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), fixed drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paraesthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized body pain, fatigue, joint pain, muscle cramps, acute renal failure, oliguria, increased serum creatinine

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. The recommended storage temperature is room temperature, between 1 and 30 degrees Celsius. This helps maintain the medication's effectiveness and safety for a prolonged period.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

30 tablets (15 tablets/ blister x 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.